Trading Journal Initial buy was good, sell was premature ( i think general market weakness and not wanting profits to turn into breakeven, sold early), should have waited).
In the end it worked out because stock gapped lower ( luck played).
Retried buy again but weakness got me to sell the next day.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.9 EUR
−268.69 M EUR
2.17 B EUR
124.65 M
About Alnylam Pharmaceuticals, Inc.
Sector
Industry
CEO
Yvonne L. Greenstreet
Website
Headquarters
Cambridge
Founded
2002
FIGI
BBG01TNW94D7
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.
ALNY, LTH & ZETA - The momentum may drive prices to new heights!Alnylam Pharmaceuticals
The stock price has encountered several rejections around the 212 level, leading to subsequent corrections.
After establishing a Double Bottom pattern, the price attempted to reverse the downward trend but was unable to do so, facing rejection at the 200 level.
Conseque
ALNY Indecision Candle w/ Tons of VolumeFound this with a volume scan on FINVIZ.
Massive indecision/high wave candle with tons of volume.
Wait for a close either above the high or below the low, and play accordingly. For example, if it closes above the high, I'd be in bullish. If it closes below the low, I'd be bearish.
Enjoy!
ALNY. Alnylam PharmaceuticalsALNY is through a corrective pullback Right now it's in a position where it can go Bullish.
But it is what I call a weak buy demand because it's 50% of the peak where it started the reversal pullback. To buy from this position, I need to see a clear reversal pattern otherwise I´ll wait for it to con
#ALNY trade plan up to 18-Aug-23Based on our team's research of the options market, we expect buy activity at the support level or sell activity at the resistance. Although the amount of money involved is not large (less thatn 1 million dollars), the size of the option position is about 50% of the typical daily volume, indicating
ALNY - 3rd Wave Could Be ImpulsiveALNY has been printing 2 corrective pattern separated waves and following an upper wicked shakeout reversal now appears to be entering a third wave that could potentially see a change up to become impulsive.
As we've seen many times now the fast wick up followed by impulsive downside is the BIG clu
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
ALNY5653584
Alnylam Pharmaceuticals, Inc. 1.0% 15-SEP-2027Yield to maturity
−4.98%
Maturity date
Sep 15, 2027
See all 1ALNY bonds
Curated watchlists where 1ALNY is featured.
Related stocks
Frequently Asked Questions
The current price of 1ALNY is 243.3 EUR — it has increased by 2.88% in the past 24 hours. Watch ALNYLAM PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange ALNYLAM PHARMACEUTICALS INC stocks are traded under the ticker 1ALNY.
1ALNY stock has risen by 7.56% compared to the previous week, the month change is a 14.17% rise, over the last year ALNYLAM PHARMACEUTICALS INC has showed a 14.17% increase.
We've gathered analysts' opinions on ALNYLAM PHARMACEUTICALS INC future price: according to them, 1ALNY price has a max estimate of 442.67 EUR and a min estimate of 187.69 EUR. Watch 1ALNY chart and read a more detailed ALNYLAM PHARMACEUTICALS INC stock forecast: see what analysts think of ALNYLAM PHARMACEUTICALS INC and suggest that you do with its stocks.
1ALNY reached its all-time high on May 2, 2025 with the price of 229.8 EUR, and its all-time low was 213.1 EUR and was reached on Apr 25, 2025. View more price dynamics on 1ALNY chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1ALNY stock is 2.79% volatile and has beta coefficient of 1.07. Track ALNYLAM PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is ALNYLAM PHARMACEUTICALS INC there?
Today ALNYLAM PHARMACEUTICALS INC has the market capitalization of 31.53 B, it has increased by 5.70% over the last week.
Yes, you can track ALNYLAM PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
ALNYLAM PHARMACEUTICALS INC is going to release the next earnings report on Jul 31, 2025. Keep track of upcoming events with our Earnings Calendar.
1ALNY earnings for the last quarter are −0.41 EUR per share, whereas the estimation was −0.82 EUR resulting in a 50.56% surprise. The estimated earnings for the next quarter are −0.63 EUR per share. See more details about ALNYLAM PHARMACEUTICALS INC earnings.
ALNYLAM PHARMACEUTICALS INC revenue for the last quarter amounts to 549.23 M EUR, despite the estimated figure of 540.87 M EUR. In the next quarter, revenue is expected to reach 556.38 M EUR.
1ALNY net income for the last quarter is −53.13 M EUR, while the quarter before that showed −80.91 M EUR of net income which accounts for 34.34% change. Track more ALNYLAM PHARMACEUTICALS INC financial stats to get the full picture.
No, 1ALNY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 7, 2025, the company has 2.23 K employees. See our rating of the largest employees — is ALNYLAM PHARMACEUTICALS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALNYLAM PHARMACEUTICALS INC EBITDA is −53.44 M EUR, and current EBITDA margin is −5.35%. See more stats in ALNYLAM PHARMACEUTICALS INC financial statements.
Like other stocks, 1ALNY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALNYLAM PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.